Human β-defensin 3 is an inducible antimicrobial peptide expressed in the respiratory tract

J. Conejo Garcia, F. Jaumann, K. Adermann, U. Forssmann, W. G. Forssmann, R. Bals (Hannover, Munich, Germany)

Source: Annual Congress 2001 - Gene and protein functions in lung function and dysfunction
Session: Gene and protein functions in lung function and dysfunction
Session type: Oral Presentation
Number: 3200
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Conejo Garcia, F. Jaumann, K. Adermann, U. Forssmann, W. G. Forssmann, R. Bals (Hannover, Munich, Germany). Human β-defensin 3 is an inducible antimicrobial peptide expressed in the respiratory tract. Eur Respir J 2001; 16: Suppl. 31, 3200

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression and function of murine WFDC2 in the respiratory tract.
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Characterisation and expression of SBEM: a novel mucin-like gene expressed in the upper respiratory tract
Source: Eur Respir J 2006; 28: Suppl. 50, 813s
Year: 2006

Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia
Source: Eur Respir J 2006; 27: 253-260
Year: 2006



Immunomodulatory effects of moxifloxacin in human respiratory tract infection
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010

Induction of the endogenous peptide LL-37/hCAP-18 expressed in bronchial epithelium by microorganisms
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002

Role of α- and β-defensins in lower respiratory tract infections
Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections
Year: 2007


Bacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper Egypt
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Makrophages regulate epithelial defence of the respiratory tract
Source: Annual Congress 2008 - Airway cell biology
Year: 2008


Evaluation of antibiotics therapy for low respiratory tract infections
Source: Eur Respir J 2007; 30: Suppl. 51, 406s
Year: 2007

Lower respiratory tract infections: bacteria and virus, antibiotics and steroids
Source: Annual Congress 2008 - Infection year in review
Year: 2008


Inhibition of upper respiratory tract inflammation leads to inhibition of lower respiratory tract inflammation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010

Role of endogenous hydrogen sulfide in the patients with lower respiratory tract infections
Source: Eur Respir J 2007; 30: Suppl. 51, 406s
Year: 2007

Antibiotic switch therapy in lower respiratory tract infections
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


Lower respiratory infection and antimicrobial resistance
Source: International Congress 2018 – New challenges in tackling known diseases with the 10 ERS Principles for Lung Health
Year: 2018


C Reactive Protein level as a marker of lower respiratory tract viral infection
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010


Rhinovirus infection differentially modulates MHC class I-related chain (MIC) A and B molecules in human respiratory epithelial cells
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


Gastrointestinal tract as a reservoir of extended spectrum β lactamases producing strains colonizing/infecting respiratory tract in infants
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010

Viral agents in children with lower respiratory tract infection
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006

Cationic host defence peptides as a novel treatment for respiratory viral infections
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018


Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009